POR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now for a short-term tactical long. POR is in a confirmed uptrend (bullish moving-average stack, MACD > 0) and options positioning is strongly call-skewed with very low put participation, suggesting constructive sentiment. With price sitting near the pivot (~49.80) and above key support (49.10), the current level offers a reasonable entry for an impatient buyer targeting a near-term push into 50.50–50.95 resistance. The main offsets are insider selling and a broadly Neutral analyst stance that implies the stock may stay range-bound until clearer catalysts, but the current technical/positioning setup still favors buying over waiting.
Trend is bullish: SMA_5 > SMA_20 > SMA_200 confirms positive structure. MACD histogram is +0.0869 (above zero) but contracting, implying upside momentum remains but is cooling (more grind than breakout). RSI_6 at 62.6 is neutral-to-slightly-warm (not overbought), leaving room for continuation. Key levels: Pivot 49.801 (price 49.92 slightly above, supportive). Support: S1 49.096 then S2 48.661 (buyers likely defend). Resistance: R1 50.506 then R2 50.941 (probable near-term targets/ceilings). Pattern-based stats also lean positive (60% chance of gains: ~+1.45% next day, +4.09% next week, +12.57% next month).
Technical uptrend with price above pivot and bullish MA stack.
Options sentiment is notably call-skewed (low put/call ratios) with low implied vol, consistent with constructive expectations.
Hedge funds are net buyers (buying amount +280.53% over the last quarter), a supportive flow signal.
Upcoming event: QDEC 2025 earnings on 2026-02-20 (pre-market) could act as a near-term catalyst if results/guide surprise to the upside.
Insider selling increased sharply (+180.45% over the last month), a near-term confidence headwind.
Analyst narrative suggests shares may be range-bound until catalysts materialize; key regulatory/corporate catalyst timing appears extended (notably referenced around mid-2026).
MACD momentum is still positive but contracting, implying upside may slow near resistance (50.50–50.95).
Latest quarter: 2025/Q3. Results show steady, utility-style growth: Revenue $952M (+2.48% YoY), Net Income $103M (+9.57% YoY), EPS $0.93 (+3.33% YoY), and Gross Margin 33.61 (+6.94% YoY). Overall: improving profitability/margins with modest top-line growth—fundamentally supportive but not a high-acceleration story.
Recent trend is predominantly Neutral/Equal Weight with price targets clustering around ~$49: Wells Fargo raised PT to $49 (Equal Weight) citing progress but extended timeline and range-bound risk; UBS lowered PT to $49 (Neutral) and previously downgraded to Neutral on valuation after a strong run; JPMorgan raised PT to $49 (Neutral); Mizuho is Neutral with a lower PT ($47); Ladenburg downgraded to Sell with PT $43 due to opposition to holding company reorganization. Wall Street pros: improving direction, some model/PT lifts, and prior optimism largely priced in. Cons: limited near-term catalysts, regulatory/timing uncertainty, and at least one outright bearish view tied to reorg opposition. Net: Street is cautious/neutral even as the tape is currently bullish.
